Immunodeficiency 14
MONDO:0014222Also known as: Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS), immunodeficiency 14, immunodeficiency 14A, autosomal dominant, immunodeficiency type 14, Activated PI3K-Delta syndrome, IMD14, p110-Delta-Activating mutation causing senescent T cells, lymphadenopathy, and immunodeficiency
47 clinical trials for this condition and its sub-types, 6 tagged with Immunodeficiency 14 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Scientists hunt for new immune disease genes in 500-Person study
Knowledge-focused Recruiting nowThis study aims to find new genes that cause immune system problems by examining up to 500 people with immune disorders and their relatives. Participants provide blood, saliva, or tissue samples and may have medical tests, but no experimental treatments are given. The goal is to …
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Scientists hunt for better ways to track rare immune disease
Knowledge-focused Recruiting nowThis study aims to find new biomarkers to better screen and monitor Activated PI3K Delta Syndrome (APDS), a rare immune disorder. Researchers will collect blood, urine, and stool samples from 14 APDS patients over two years to analyze changes in immune cells and other markers. Th…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC